212 related articles for article (PubMed ID: 18036657)
1. Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab.
Rossi D; Ramponi A; Franceschetti S; Stratta P; Gaidano G
Leuk Res; 2008 May; 32(5):829-34. PubMed ID: 18036657
[TBL] [Abstract][Full Text] [Related]
2. Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
Svoboda J; Kotloff R; Tsai DE
Transpl Int; 2006 Apr; 19(4):259-69. PubMed ID: 16573540
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in association with rapamycin for post-transplant lymphoproliferative disease treatment.
Garcia VD; Bonamigo Filho JL; Neumann J; Fogliatto L; Geiger AM; Garcia CD; Barros V; Keitel E; Bittar AE; Ferrera des Santos A; Roithmann S
Transpl Int; 2003 Mar; 16(3):202-6. PubMed ID: 12664217
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission.
Knoop C; Kentos A; Remmelink M; Garbar C; Goldman S; Feremans W; Estenne M
Clin Transplant; 2006; 20(2):179-87. PubMed ID: 16640524
[TBL] [Abstract][Full Text] [Related]
5. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.
Cornejo A; Bohnenblust M; Harris C; Abrahamian GA
Cancer Chemother Pharmacol; 2009 Sep; 64(4):857-60. PubMed ID: 19588139
[TBL] [Abstract][Full Text] [Related]
6. Rituximab as treatment of posttransplant lymphoproliferative disorder in patients who underwent small bowel/multivisceral transplantation: report of three cases.
Codeluppi M; Cocchi S; Guaraldi G; Di Benedetto F; Bagni A; Pecorari M; Gennari W; Pinna AD; Gerunda GE; Esposito R
Transplant Proc; 2005; 37(6):2634-5. PubMed ID: 16182770
[TBL] [Abstract][Full Text] [Related]
7. Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus.
Kaposztas Z; Etheridge WB; Kahan BD
Transplant Proc; 2008 Jun; 40(5):1744-6. PubMed ID: 18589184
[TBL] [Abstract][Full Text] [Related]
8. A case of post-transplant lymphoproliferative disease presenting as CD20-expressing, Epstein-Barr-virus positive Hodgkin lymphoma.
Stern M; Herrmann R; Rochlitz C; Dirnhofer S; Pless M
Eur J Haematol; 2005 Mar; 74(3):267-70. PubMed ID: 15693799
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disorder treated with rituximab: case report.
Meng HT; Li Y; Liu JH; Xu GX; Teng XD
Chin Med J (Engl); 2007 May; 120(9):841-3. PubMed ID: 17531130
[No Abstract] [Full Text] [Related]
11. Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child.
Hayashida M; Ogita K; Matsuura T; Takahashi Y; Nishimoto Y; Ohga S; Hara T; Soejima Y; Taketomi A; Maehara Y; Kohashi K; Tsuneyoshi M; Taguchi T
Pediatr Transplant; 2007 Sep; 11(6):671-5. PubMed ID: 17663692
[TBL] [Abstract][Full Text] [Related]
12. Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemia.
Rudzki Z; Werda L; Piatkowska-Jakubas B; Mensah P; Zazula M; Białas M; Skotnicki AB; Stachura J
Pol J Pathol; 2002; 53(1):35-40. PubMed ID: 12014224
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
[TBL] [Abstract][Full Text] [Related]
14. Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.
Francescone SA; Murphy B; Fallon JT; Hammond K; Pinney S
Transplant Proc; 2009 Jun; 41(5):1946-8. PubMed ID: 19545762
[TBL] [Abstract][Full Text] [Related]
15. Rapid response to rituximab in a pediatric liver transplant recipient with post-transplant lymphoproliferative disease and maintenance with sirolimus monotherapy.
Al-Akash SI; Al Makadma AS; Al Omari MG
Pediatr Transplant; 2005 Apr; 9(2):249-53. PubMed ID: 15787802
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
Cheng FW; Lee V; To KF; Chan KC; Shing MK; Li CK
Pediatr Blood Cancer; 2009 Dec; 53(7):1329-31. PubMed ID: 19591223
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
van de Glind G; de Graaf S; Klein C; Cornelissen M; Maecker B; Loeffen J
Pediatr Blood Cancer; 2008 Apr; 50(4):886-8. PubMed ID: 17668865
[TBL] [Abstract][Full Text] [Related]
18. Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.
Lee JJ; Lam MS; Rosenberg A
Ann Pharmacother; 2007 Oct; 41(10):1648-59. PubMed ID: 17848421
[TBL] [Abstract][Full Text] [Related]
19. [Clinico-pathological analysis of 6 cases of post-transplant lymphoproliferative disorders].
Wang ZM; Zheng SS; Ding W; Wang LJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):514-8. PubMed ID: 18078125
[TBL] [Abstract][Full Text] [Related]
20. A rare case of plasmacytoma-like post-transplant lymphoproliferative disorder presenting in the skin of a lung transplant patient.
McFarlane R; Hurst S; Sabath D; George E; Argenyi Z
J Cutan Pathol; 2008 Jun; 35(6):599-602. PubMed ID: 18201236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]